Fingerprint
Dive into the research topics of 'Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: A translational perspective'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically